Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study

Our real-world data confirms that FILGO is safe and effective for patients with UC. Its efficacy is significantly improved when used as a first-line treatment.

Authors

Institutions

Publication Details

Journal
Intestinal Research
Published
2025-09-29
DOI
https://doi.org/10.5217/ir.2025.00067
Citations
1
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
1.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study

Fabio Cortellini, P. Capone, Raffaele Pellegrino, Maria Giovanna Graziani et al.
1 citations
Intestinal Research
Inflammatory Bowel Disease
1.82
article

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study

Fabio Cortellini, P. Capone, Raffaele Pellegrino, Maria Giovanna Graziani, Antonietta Gerarda Gravina, Alessia Immacolata Cazzato, Daniele Napolitano, L. Donnarumma, Antonio Tursi, Francesco Costa, Michela Di Fonzo, Rosario D’Onofrio, A. Scarcelli, Andrea Pasta, Giovanni Maconi, Nataša Šebková, Federica Gaiani, Riccardo Aragona, Mauro Allegretta, Stefano Rodinò, Caterina Mucherino, Cristiano Pagnini, E D'Antonio, Laura Montesano, F. Luzza, Giovanni Cataletti, Marcello Picchio, Franco Scaldaferri, Gabriella Serio, Alfredo Papa, Stefano Kayali, Giammarco Mocci, Giorgia Bodini, Silvia Sedda, Rocco Spagnuolo, Walter Elisei, Daniela Pugliese, Francesca Maria Onidi, Edoardo Vincenzo Savarino, C. Cassieri, Giacomo Forti, Simona Piergallini, Lorenzo Bertani, Davide Giuseppe Ribaldone, Patrizia Perazzo, Antonio Ferronato, Federico Iacopini, Manuela Marzo, Paolo Usai–Satta, Giuliana Vespere, Maria Carla Di Paolo, Roberta Pica, Antonio Cuomo, Leonardo De Luca, Stefano Scorza, Linda Ceccarelli, Caterina De Barba
article en
1 citations

Abstract

Our real-world data confirms that FILGO is safe and effective for patients with UC. Its efficacy is significantly improved when used as a first-line treatment.

Intestinal Research
Università Cattolica del Sacro Cuore (IT), University of Parma (IT), University of Padua (IT), Azienda Ospedaliera San Giovanni Addolorata (IT), Policlinico Umberto I (IT), Martin University (US), Agostino Gemelli University Polyclinic (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Luigi Sacco Hospital (IT), Azienda Ospedaliera San Camillo-Forlanini (IT), AULSS 2 Marca Trevigiana (IT), San Salvatore Hospital (IT), Ospedale Sant'Anna (IT), Department of Medical Sciences (RU), CTO Andrea Alesini (IT), Ospedale Veris Delli Ponti Scorrano (IT), University of Campania "Luigi Vanvitelli" (IT), Ospedale Infermi di Rimini (IT), IRCCS San Camillo Hospital (IT), Nini Hospital (LB), Ospedale L. Bonomo (IT), Guglielmo da Saliceto Hospital (IT), Ospedale Santa Maria Goretti (IT), Ospedale Policlinico San Martino (IT), Azienda Ospedaliera Pugliese Ciaccio (IT), Ospedale Sant'Anna (IT), Ospedale D. Cotugno (IT), Carlo Forlanini Hospital (IT), Ospedale Eugenio Morelli (IT), Azienda Usl Toscana Centro (IT), Azienda Sanitaria Locale Roma 3 (IT), Azienda Ospedaliera G. Brotzu (IT)
Openalex Percentile: Top 12%
Inflammatory Bowel Disease
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.